DSK Biopharma develops lipid-based compounds, including ionizable lipids and cholesterol derivatives, crucial for lipid nanoparticle (LNP) formulations used in mRNA, siRNA, and DNA delivery systems.
Key Highlights:
GMP-compliant synthesis of PEG-lipids, ionizable lipids, and structural lipids
Batch-to-batch reproducibility for formulation consistency
Scale-up support for preclinical and clinical use
We ensure pharmaceutical-grade quality and consistency for cutting-edge LNP drug delivery platforms.